Clinical trial
Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer…
NCT00040560 · Copharos, Industry · Unknown status
Key facts
| NCT number | NCT00040560 |
|---|---|
| Title | Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer |
| Lead sponsor | Copharos, Industry |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Brain Neoplasms, Metastases, Neoplasm |
| Intervention type | Drug, Procedure |
| Interventions | 111In-DAC, Diagnostic |
| First posted | Jul 2, 2002 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: